Literature DB >> 18701534

Lipid modification: cardiovascular risk assessment and the modification of blood lipids for the primary and secondary prevention of cardiovascular disease.

J Robson1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2008        PMID： 18701534     DOI： 10.1136/hrt.2008.150979

Source DB:  PubMed          Journal:  Heart        ISSN： 1355-6037            Impact factor:   5.994


× No keyword cloud information.
  119 in total

Review 1.  Fixed-dose combination therapy for the prevention of atherosclerotic cardiovascular diseases.

Authors:  Ehete Bahiru; Angharad N de Cates; Matthew Rb Farr; Morag C Jarvis; Mohan Palla; Karen Rees; Shah Ebrahim; Mark D Huffman
Journal:  Cochrane Database Syst Rev       Date:  2017-03-06

Review 2.  Risk assessment and lipid modification for primary and secondary prevention of cardiovascular disease: summary of NICE guidance.

Authors:  Angela Cooper; Norma O'Flynn
Journal:  BMJ       Date:  2008-05-31

3.  High total serum cholesterol, medication coverage and therapeutic control: an analysis of national health examination survey data from eight countries.

Authors:  Gregory A Roth; Stephan D Fihn; Ali H Mokdad; Wichai Aekplakorn; Toshihiko Hasegawa; Stephen S Lim
Journal:  Bull World Health Organ       Date:  2010-09-03       Impact factor: 9.408

4.  Fixed-dose combination therapy for the prevention of cardiovascular disease.

Authors:  Angharad N de Cates; Matthew Rb Farr; Karen Rees; Juan P Casas; Mark Huffman
Journal:  Cochrane Database Syst Rev       Date:  2012

5.  Automated electronic reminders to facilitate primary cardiovascular disease prevention: randomised controlled trial.

Authors:  Tim A Holt; Margaret Thorogood; Frances Griffiths; Stephen Munday; Tim Friede; David Stables
Journal:  Br J Gen Pract       Date:  2010-04       Impact factor: 5.386

6.  General practice by numbers: presentation to final outcome.

Authors:  Mark Shapley; Gemma Mansell; Kevin Barraclough; Peter Croft
Journal:  Br J Gen Pract       Date:  2013-04       Impact factor: 5.386

7.  Cholesterol level influences opioid signaling in cell models and analgesia in mice and humans.

Authors:  Hui Zheng; Haibo Zou; Xiaopeng Liu; Ji Chu; Yali Zhou; Horace H Loh; Ping-Yee Law
Journal:  J Lipid Res       Date:  2012-02-29       Impact factor: 5.922

8.  Unintended effects of statins in men and women in England and Wales: population based cohort study using the QResearch database.

Authors:  Julia Hippisley-Cox; Carol Coupland
Journal:  BMJ       Date:  2010-05-20

9.  An independent and external validation of QRISK2 cardiovascular disease risk score: a prospective open cohort study.

Authors:  Gary S Collins; Douglas G Altman
Journal:  BMJ       Date:  2010-05-13

10.  An independent external validation and evaluation of QRISK cardiovascular risk prediction: a prospective open cohort study.

Authors:  Gary S Collins; Douglas G Altman
Journal:  BMJ       Date:  2009-07-07
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.